NCT02236078View on ClinicalTrials.gov

Brief Bactericidal Activity of Anti-Tuberculosis Drugs

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

September 30, 2020

Study Completion Date

September 30, 2020

Conditions
TuberculosisDrug-resistant TuberculosisIsoniazid Resistant Tuberculosis (Disorder)
Interventions
DRUG

High dose isoniazid

See arm description

Trial Locations (1)

Unknown

National Institute for Research on Tuberculosis, Chennai

Sponsors
All Listed Sponsors
collaborator

Kenya Medical Research Institute

OTHER

lead

Centers for Disease Control and Prevention

FED

NCT02236078 - Brief Bactericidal Activity of Anti-Tuberculosis Drugs | Biotech Hunter | Biotech Hunter